Analysts have mixed ratings for Evolent Health, with a slight bearish sentiment
From Nasdaq: 2025-05-09 18:00:00
Analysts’ ratings for Evolent Health (NYSE: EVH) vary from bullish to bearish, with 9 analysts providing insights over the last quarter. Recent ratings show a mix of bullish and somewhat bullish sentiments, with a total of 4 bullish ratings. The average price target is $13.89, with a high estimate of $16.00 and a low estimate of $12.00, indicating a 0.79% drop from the previous average target of $14.00.
An in-depth analysis of analyst actions reveals updates on ratings and price targets for Evolent Health. Analysts like Kevin Caliendo from UBS have raised their rating to Buy with a price target of $15.00, while others like Anne Samuel from JP Morgan have lowered their rating to Overweight with a price target of $12.00. These actions reflect analysts’ reactions to market conditions and company performance.
Evolent Health Inc specializes in healthcare delivery and payment, supporting health systems and physician organizations in value-based care. The company’s financial overview shows notable revenue growth of 16.27% as of Dec 31, 2024, with a strong net margin of -4.74% and ROE of -3.0%. Analyst ratings provide insights based on revenue predictions and company performance, offering guidance for investors. Stay informed with updated analyst ratings on Benzinga Pro for potential investment opportunities.
Read more at Nasdaq: Expert Outlook: Evolent Health Through The Eyes Of 9 Analysts